NIFTY 50▲24,304.35
99.00 (0.41%)
SENSEX▲79,724.12
335.06 (0.42%)
NIFTY BANK▲51,673.90
198.55 (0.39%)
TATA MOTORS▲843.45
9.40 (1.13%)
SUZLON ENERGY▲68.14
1.19 (1.78%)
TATA STEEL▲149.75
1.19 (0.80%)
INDIAN RAILWAY FINANCE CORP▲158.11
2.15 (1.38%)
TATA POWER▲445.45
5.40 (1.23%)
RAIL VIKAS NIGAM▼470.95
-0.85 (-0.18%)
RELIANCE INDUSTRIES▲1,338.65
6.60 (0.50%)
VODAFONE IDEA▲8.45
0.33 (4.06%)
ZOMATO▲248.99
7.24 (2.99%)
RELIANCE POWER▲43.03
0.30 (0.70%)
INDIAN RENEWABLE ENERGY▲211.98
1.94 (0.92%)
ADANI POWER▲597.35
4.65 (0.78%)
YES BANK▲20.71
0.31 (1.52%)
STATE BANK OF INDIA▲821.20
1.00 (0.12%)
NHPC▲84.13
1.53 (1.85%)
HDFC BANK▲1,737.30
1.60 (0.09%)
OLA ELECTRIC MOBILITY LTD▲82.84
1.96 (2.42%)
JIO FIN SERVICES LTD▲326.20
3.90 (1.21%)
INDIAN OIL CORP▲144.99
2.37 (1.66%)
BHARAT ELECTRONICS▲288.65
3.75 (1.32%)
MRF▲1,23,379.95
855.50 (0.70%)
GTL INFRA▲2.18
0.10 (4.81%)
ADANI PORT & SEZ▲1,394.40
18.45 (1.34%)
JAIPRAKASH POWER VENTURES▲18.47
0.27 (1.48%)
ITC▲490.30
1.50 (0.31%)
Caplin Point Lab Share Price
CAPLIPOINT
₹2,024.75-₹10.65 (-0.52%) TodayLast updated on 01 Nov, 2024 | 19:19 IST
Caplin Point Lab Share Price Chart
Please wait...
About Caplin Point Lab
Caplin Point Lab Financials
Market cap ₹15,471 Crs | Open ₹2,044.95 | Close ₹2,035.40 |
Circuit range ₹2,429.70 - ₹1,619.80 | Day range ₹2,005.50 - ₹2,058.95 | Year range ₹1,050.20 - ₹2,158.80 |
Volume 23,597 | Avg. traded ₹2,033.19 | Revenue (12m) ₹1,758 Crs |
Caplin Point LabCaplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Caplin Point Lab Key indicators
52 week high ₹2,158.80 | 52 week low ₹1,050.20 | P/E ratio 32.48 |
P/B ratio 6.06 | ROE 22.69% | ROCE 28.92% |
Dividend yield 0.26% | Debt/Equity ratio | EPS 37.35 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 2 experts in the last 7 days
Caplin Point Lab Fundamentals
Caplin Point Lab Financial Ratios
Operating profit margin62.86% | Net profit margin45.39% |
ROE22.69% | ROA20.08% |
ROCE28.92% |
Learn more
Caplin Point Lab Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Fri, Nov 1 2024 | ₹2,044.95 | ₹2,024.75 | -0.52% |
Thu, Oct 31 2024 | ₹1,975.05 | ₹2,035.40 | |
Wed, Oct 30 2024 | ₹1,865.70 | ₹1,979.50 | |
Tue, Oct 29 2024 | ₹1,804.95 | ₹1,869.00 | |
Mon, Oct 28 2024 | ₹1,794.20 | ₹1,804.95 | |
Fri, Oct 25 2024 | ₹1,864.45 | ₹1,790.70 | -3.96% |
Thu, Oct 24 2024 | ₹1,835.65 | ₹1,864.45 | |
Wed, Oct 23 2024 | ₹1,860.00 | ₹1,829.20 | -2.34% |
Events
Corporate actions
Dividend • ₹2.5/share
Ex date 31 May 2024
Dividend • ₹2.5/share
Ex date 14 Sep 2023
Dividend • ₹2/share
Ex date 09 Jun 2023
Dividend • ₹2/share
Ex date 21 Sep 2022
Dividend • ₹2/share
Ex date 23 May 2022
Dividend • ₹2.5/share
Ex date
Learn more
More